Reaction Details Report a problem with these data
Target
P2Y purinoceptor 12
Ligand
BDBM50445214
Substrate
n/a
Meas. Tech.
ChEMBL_1284762 (CHEMBL3107659)
IC50
>20000±n/a nM
Citation
Qiao, JX; Wang, TC; Ruel, R; Thibeault, C; L'Heureux, A; Schumacher, WA; Spronk, SA; Hiebert, S; Bouthillier, G; Lloyd, J; Pi, Z; Schnur, DM; Abell, LM; Hua, J; Price, LA; Liu, E; Wu, Q; Steinbacher, TE; Bostwick, JS; Chang, M; Zheng, J; Gao, Q; Ma, B; McDonnell, PA; Huang, CS; Rehfuss, R; Wexler, RR; Lam, PY Conformationally constrained ortho-anilino diaryl ureas: discovery of 1-(2-(1'-neopentylspiro[indoline-3,4'-piperidine]-1-yl)phenyl)-3-(4-(trifluoromethoxy)phenyl)urea, a potent, selective, and bioavailable P2Y1 antagonist. J Med Chem 56:9275-95 (2013) [PubMed] Article
More Info.:
Target
Name:
P2Y purinoceptor 12
Synonyms:
ADP-glucose receptor | ADPG-R | HORK3 | P2RY12 | P2T(AC) | P2Y purinoceptor 12 | P2Y(AC) | P2Y(ADP) | P2Y(cyc) | P2Y12 | P2Y12 platelet ADP receptor | P2Y12_HUMAN | Purinergic receptor P2Y12 | SP1999
Type:
Enzyme
Mol. Mass.:
39458.48
Organism:
Homo sapiens (Human)
Description:
Q9H244
Residue:
342
Sequence:
MQAVDNLTSAPGNTSLCTRDYKITQVLFPLLYTVLFFVGLITNGLAMRIFFQIRSKSNFIIFLKNTVISDLLMILTFPFKILSDAKLGTGPLRTFVCQVTSVIFYFTMYISISFLGLITIDRYQKTTRPFKTSNPKNLLGAKILSVVIWAFMFLLSLPNMILTNRQPRDKNVKKCSFLKSEFGLVWHEIVNYICQVIFWINFLIVIVCYTLITKELYRSYVRTRGVGKVPRKKVNVKVFIIIAVFFICFVPFHFARIPYTLSQTRDVFDCTAENTLFYVKESTLWLTSLNACLDPFIYFFLCKSFRNSLISMLKCPNSATSLSQDNRKKEQDGGDPNEETPM